Skip to main content
Home
    • en
    • fr

  • Search form

Main menu

  • About us
    • Our mission
    • Facts & Figures
    • Our Strategy
    • Corporate Governance/ Executive Committee
    • bioMérieux Worldwide
    • Our History
    • Innovation
    • Institut Mérieux

  • Responsibility
    • Our commitments
    • Responsibility to society
    • Responsibility to our workforce
    • Responsibility to the environment
    • Ethics & Compliance
    • Sustainable and socially inclusive purchasing
    • Global Compact
    • Internal Audit & Risks
    • FONDATION MÉRIEUX
    • OUR EMPLOYEE'S SUCCESS
  • Solutions
    • Clinical Solutions
    • Industry Solutions
    • Product Quality & Safety
    • Customer Service
    • Cybersecurity & data privacy
    • Technical Library
    • CLINICAL SOLUTIONS
    • INDUSTRY SOLUTIONS
  • Expertise
    • The importance of diagnostics
      • Clinical diagnostics
      • Industrial Microbiological Control
    • Clinical applications
      • Infectious diseases
      • Antimicrobial resistance and Healthcare-associated infections
      • Cardiovascular Emergencies
      • Personalized medicine
    • Industrial applications
      • Agri-food sector
      • Biopharma & cosmetics sectors
    • Our technologies, systems and services
      • Microbiology
      • Molecular Biology
      • Immunoassays
      • Laboratory efficiency
    • Glossary of Scientific Terms
  • Education
    • Antimicrobial Resistance / Antimicrobial Stewardship
      • Webinars
      • Educational Materials
      • External Resources
    • Sepsis / Bloodstream Infections
      • Webinars
      • Educational Materials
      • External Resources
    • COVID-19
      • Webinars
    • Educational booklets
  • Investors
    • The bioMérieux Share
    • Publications
    • Regulated Information
    • Governance
    • Shareholder area
    • UNIVERSAL REGISTRATION DOCUMENT
    • CORPORATE SOCIAL RESPONSIBILITY
  • Newsroom
    • Press Releases
    • Corporate calendar
    • Media Center
    • About bioMérieux
    • Launch of BIOFIRE® MYCOPLASMA test for mycoplasma detection in biopharmaceutical products
    • PRESS CONTACTS
  • Careers
    • Sharing our vision
    • Joining bioMérieux
    • Learning, development and growth
    • Well-being at work
    • Embracing Diversity and Inclusion
    • SHARING OUR VISION
    • JOB PROFILES
  • Contact us
Home
  • About us
    • Our mission
    • Facts & Figures
    • Our Strategy
    • Corporate Governance/ Executive Committee
    • bioMérieux Worldwide
    • Our History
    • Innovation
    • Institut Mérieux
  • Responsibility
    • Our commitments
    • Responsibility to society
    • Responsibility to our workforce
    • Responsibility to the environment
    • Ethics & Compliance
    • Sustainable and socially inclusive purchasing
    • Global Compact
    • Internal Audit & Risks
  • Solutions
    • Clinical Solutions
    • Industry Solutions
    • Product Quality & Safety
    • Customer Service
    • Cybersecurity & data privacy
    • Technical Library
  • Expertise
    • The importance of diagnostics
    • Clinical applications
    • Industrial applications
    • Our technologies, systems and services
    • Glossary of Scientific Terms
  • Education
    • Antimicrobial Resistance / Antimicrobial Stewardship
    • Sepsis / Bloodstream Infections
    • COVID-19
    • Educational booklets
  • Investors
    • The bioMérieux Share
    • Publications
    • Regulated Information
    • Governance
    • Shareholder area
  • Newsroom
    • Press Releases
    • Corporate calendar
    • Media Center
    • About bioMérieux
  • Careers
    • Sharing our vision
    • Joining bioMérieux
    • Learning, development and growth
    • Well-being at work
    • Embracing Diversity and Inclusion
  • Contact us
    • Investor Relations
    • en
    • fr

  • Search form

You are here

Printer-friendly version
  • Home
  • Investors
  • Governance
  • Status
Investors
  • The bioMérieux Share
    • Stock Market Information
    • Historic Chart
    • Analysts Coverage
    • Analysts Consensus
  • Publications
    • Calendar
    • Press Releases
    • Presentations
    • Annual Reports
    • Universal Registration Documents
  • Regulated Information
  • Governance
    • Regulated Agreements
    • Status
    • Board Charter
  • Shareholder area
    • General Shareholders' Meeting
    • Participating In The General Shareholder's Meeting
    • Dividends
    • Crossing the Thresholds

Status

Press Release
  • July 16, 2020 Launch of BIOFIRE® MYCOPLASMA test for mycoplasma detection in bio...
  • July 15, 2020 BIOFIRE® Respiratory Panel 2.1 plus with SARS-CoV-2 is CE marked ...
  • July 09, 2020 Second-Quarter 2020 Business Performance Preannouncement
  • May 21, 2020 CE marking of bioMérieux serology tests for SARS-CoV-2 on VIDAS® ...
Annual Report

Industry Solutions

To discover all of our products for industrial microbiological control, please visit our bioMérieux Industry website.

Clinical Solutions

To discover all of our products for Clinical applications, please visit bioMérieux Diagnostics website.

Download the bioMérieux SA Articles of Association

Updated May 17th, 2018

Pioneering diagnostics
  • Legal Notice
  • Privacy
  • Cookie Policy
  • Contact
  • Copyright 2020 bioMérieux SA
  • biomerieux.com
  • bioMérieux Worldwide >
    Discover all our locations
    Asia
    • China (Website)
    • India (Website)
    • Indonesia (website)
    • Japan (Website)
    • Korea
    • Malaysia (website)
    • Philippines (website)
    • Singapore (Website)
    • Thailand (website)
    • Vietnam (website)
    Europe, Middle East, Africa
    • Algeria
    • Austria (Website)
    • Belgium
    • Czech Republic (Website)
    • Denmark (Website)
    • Finland (Website)
    • France (Website)
    • Germany (Website)
    • Greece
    • Hungary (Website)
    • Italy (Website)
    • Ivory Coast
    • Netherlands
    • Norway (Website)
    • Poland (Website)
    • Portugal (Website)
    • Russia (Website)
    • Serbia
    • South Africa (Website)
    • Spain (Website)
    • Sweden (Website)
    • Switzerland (Website)
    • Turkey (Website)
    • United Arab Emirates
    • United Kingdom (Website)
    North America
    • Canada (Website)
    • United States (Website)
    Oceania
    • Australia (Website)
    • New Zealand (Website)
    South America
    • Argentina (Website)
    • Brazil (Website)
    • Chile (Website)
    • Colombia (Website)
    • Mexico (Website)
  • Our Specific Websites >
    • Antimicrobial Resistance Website
    • bioMérieux Clinical Diagnostics
    • bioMérieux Industry
    • bioMérieux Recruitment
    • bioMérieux Culture Media
  • Our communities >
    • mybiomerieux.com